| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 742327 | (3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone | 0.024108502230778 | 0.38193291 |
| NSC 757949 | (1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one | 0.024108502230778 | -0.30976364 |
| NSC 96996 | B 169 | 0.024108502230778 | 0.48230028 |
| NSC 1 | Methylbenzoquinone | 0.0241085022307781 | 0.60005169 |
| NSC 254677 | Phomazarin | 0.0241085022307781 | -0.04537223 |
| NSC 105014 | Cladribine | 0.0247979034812109 | 0.11326866 |
| NSC 135687 | 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) | 0.0247979034812109 | 0.27116637 |
| NSC 148790 | Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) | 0.0247979034812109 | 0.19568725 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0247979034812109 | 0.21925125 |
| NSC 185065 | Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- | 0.0247979034812109 | 0.49972422 |